Oncology Information System Features New Interface

March 31, 2011 – An oncology information system now includes an interface to radiotherapy systems. Elekta’s Mosaiq version 2.20 now has an interface to Xstrahl’s superficial and orthovoltage radiotherapy systems, enabling users of these therapy machines to prepare, deliver and record treatments via Mosaiq.

The Xstrahl family of treatment systems treats superficial tumors and benign lesions (e.g., basal cell and squamous cell carcinomas, keloid scars and dermatological conditions) with low-energy radiation.

The first two users, Sequoia Hospital in Redwood City, Calif., and St. James’s University Hospital, in Leeds, U.K., have reported success at their institutions.

“Mosaiq 2.20 is recording and verifying the treatments we’re giving patients, which is very important to us,” says Helen Monk, manager, radiation oncology at Sequoia Hospital. “Mosaiq helps ensure that every step we’re taking is correct. If a setting or filter has somehow been set incorrectly on the Xstrahl system, the machine will not turn on because it does not match what we set in Mosaiq. If you’re working by yourself, it’s nice to have that added comfort knowing that Mosaiq is double-checking everything you do to ensure safety.”

St. James’s University Hospital’s Peter Enever, advanced practitioner, agrees with the added assurance of safety that the new interface brings.

“You can’t get the combination of filters and applicators wrong,” he said. “The intelligent ‘engine’ in Mosaiq automatically drives the workflow and checks that each step has been done correctly. From our point of view that is a very good safety feature and it gives users added confidence in what they’re doing.”

Enever added that the interface’s similarity to that of a linear accelerator made training literally a five-minute process. “It looks and behaves exactly the same way as a linac interface,” he said. “St. James’s Institute of Oncology’s aspiration to achieve a single integrated patient pathway has moved one step closer with the introduction of the MOSAIQ-Xstrahl interface.”

For more information: www.elekta.com

Related Content

News | Breast Imaging

September 27, 2023 — Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two ...

Time September 27, 2023
Feature | ASTRO | By Christine Book

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
News | Radiation Oncology

September 6, 2023 — Nina D’Abreo, MD, has been named as chief of the Division of Hematology and Medical Oncology at NYU ...

Time September 06, 2023
News | Radiation Oncology

August 30, 2023 — Elekta and the IAEA have signed a partnership agreement to jointly pursue common interests, including ...

Time August 30, 2023
News | Radiopharmaceuticals and Tracers

August 28, 2023 — TerraPower Isotopes and PanTera, the Belgian joint venture created by SCK CEN and IBA, announced that ...

Time August 28, 2023
News | Radiology Business

July 27, 2023 — Privately-held biotech company TAE Life Sciences has announced that its board of directors has appointed ...

Time July 27, 2023
Subscribe Now